MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
January 4, 2005
Rich Smith
Blood for Sale Cord blood harvester ViaCell moves closer to its IPO, with pricing to be in the $7 to $9 range and will float 7.5 million shares, though still on a date "to be announced." mark for My Articles similar articles
The Motley Fool
March 2, 2005
Rich Smith
ViaCell Under the Microscope Cord blood collector makes its first earnings announcement tomorrow. Investors will likely be shining harsh lights on the company's financial statements. mark for My Articles similar articles
The Motley Fool
February 23, 2007
Rich Smith
Foolish Forecast: ViaCell Doing Well? The cord blood specialist is set to report its fourth-quarter and full-year 2006 numbers shortly. Investors, here is what you can expect to see. mark for My Articles similar articles
The Motley Fool
August 13, 2007
Rich Smith
ViaCell Sees the Light Despite rising sales at its trademark ViaCord umbilical cord blood storage service, and gross margin from this service rising in tandem, the firm's operating and net results remain mired in thick red ink. Investors, take note. mark for My Articles similar articles
The Motley Fool
May 4, 2006
Rich Smith
ViaCell Looking Sickly As expected, the company remains solvent by virtue of one division: its ViaCord umbilical cord blood storage unit, which provided $11.9 million of the quarter's $12.1 million in revenues. But even that good news fails to outweigh the bad news. Investors, take note. mark for My Articles similar articles
The Motley Fool
April 18, 2005
Rich Smith
U.S. Government Out for Blood Two companies await as the Institute of Medicine advocates improvements in cord blood banking. Newly public ViaCell has been plummeting along with rival Cryo-Cell, down roughly 40% over the past three months. mark for My Articles similar articles
The Motley Fool
August 2, 2006
Rich Smith
Foolish Forecast: Anemic ViaCell The cord blood storage specialist is due to report its second quarter 2006 numbers tomorrow. Investors, take note. mark for My Articles similar articles
The Motley Fool
September 20, 2005
Rich Smith
ViaCell's Cancer Trial Snag The cord blood collector suffers a research setback. Investors should keep in mind that the real money-maker behind ViaCell is its ViaCord cord blood storage business. mark for My Articles similar articles
The Motley Fool
November 8, 2005
Rich Smith
ViaCell Looks Healthier The cord blood collector reports narrowing losses. Investors, take note. mark for My Articles similar articles
The Motley Fool
April 27, 2007
Rich Smith
Foolish Forecast: ViaCell Doing Swell? The cord blood specialist is set to release its first-quarter 2007 earnings. Investors, here is what you can expect to see. mark for My Articles similar articles
The Motley Fool
November 30, 2004
Rich Smith
Breaking Rules and Saving Lives Cord blood offers an ethical means of using stem cells to heal illness. While two top companies in the field are private, over the counter traded Cryo-Cell lost as much money as it collected in revenues last year. mark for My Articles similar articles
The Motley Fool
October 2, 2007
Brian Orelli
PerkinElmer and ViaCell: A Bloody Good Deal? PerkinElmer buys umbilical cord storage company ViaCell for $300 million. Investors, take note; the merger may be a good fit for both companies. mark for My Articles similar articles
The Motley Fool
August 8, 2006
Rich Smith
Second Opinion on ViaCell The prognosis isn't good. Is there still hope for ViaCell? Of course! Hope springs eternal. If ViaCell can just tighten its purse strings, investors may yet find a way to save blood and make money. mark for My Articles similar articles
The Motley Fool
October 5, 2005
Rick Aristotle Munarriz
Sirius Challenge The fourth quarter is going to be critical in the history of satellite radio. This holiday period is what will either justify the stock's considerable market cap or doom the company to fall even further behind XM Satellite Radio in subscriber count. mark for My Articles similar articles
BusinessWeek
June 27, 2005
Arlene Weintraub
Stem Cells To Go ViaCell's goal is to mass-produce stem cells from umbilical cord blood. mark for My Articles similar articles
The Motley Fool
March 17, 2009
Rick Aristotle Munarriz
Sirius Is a 5-Bagger Sirius XM Radio has bounced back since last month. mark for My Articles similar articles
The Motley Fool
May 22, 2008
Rick Aristotle Munarriz
Get TiVo for Free TiVo will be offering its namesake digital video recorder without monthly subscription fees in Australia. Would that strategy work closer to home? mark for My Articles similar articles
The Motley Fool
January 18, 2006
Rick Aristotle Munarriz
Stock Predictions for 2006 Five new market calls for the year ahead: Shares of Google will fall... XM will regain the lead in new net subscribers over Sirius... Both XM and Sirius will close out 2006 at higher prices... etc. mark for My Articles similar articles
The Motley Fool
February 23, 2006
Rich Smith
Dueling Fools: TiVo Bear TiVo isn't profitable now, when it has DirecTV carrying its water. In about a year, its biggest ally will become a competitor, cutting off the flow of new TiVo customers and stealing away existing ones. Investors, take note. mark for My Articles similar articles
The Motley Fool
May 13, 2006
Rick Aristotle Munarriz
A Fool Looks Back Downloads and down lows highlighted the past week: TiVo is a video star... IPO ETF, FYI... mark for My Articles similar articles
The Motley Fool
June 29, 2004
Selena Maranjian
Wall Street Ticked Off at Google More work for less payoff has many investment banks grumbling. mark for My Articles similar articles
The Motley Fool
May 26, 2004
Bill Mann
Going Dutch With Google The author has everything you wanted to know about the Google IPO but were afraid to ask. Sometime in the next 12 months, Google, the massive search engine company, is going to hold its initial public offering, placing a portion of company stock into the public markets. mark for My Articles similar articles
The Motley Fool
April 16, 2008
Rick Aristotle Munarriz
What Now, Satellite Radio? It's taking the FCC way too long to clear the Sirius/XM Satellite deal that the Department of Justice approved last month. mark for My Articles similar articles
The Motley Fool
March 5, 2007
Rich Smith
ViaCell Not Doing Well The company's biotech half continues to sap revenue from the moneymaking side. Investors, take note. mark for My Articles similar articles
The Motley Fool
May 3, 2011
Dan Caplinger
Be a Smarter IPO Investor Some IPOs soar and others bomb. Be aware of the traps. mark for My Articles similar articles